Earnings Call · Q2 FY2022·2021-11-23

Q2 22EPS +2.33%·Rev n/aQ1 22EPS +6.82%·Rev n/aQ4 21EPS +5.63%·Rev n/aQ3 21EPS +12.17%·Rev n/a⚠ consensus missing

Medtronic plc MDT

Ryan Weispfenning — Vice President and Head of Investor Relations

Geoffrey Martha — Chairman and Chief Executive Officer

Karen Parkhill — Executive Vice President and Chief Financial Officer

−3.0%1d on move date−3.1% vs SPY3d−5.0%5d−8.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MDT calls or request research access.

More MDT calls Browse calls Request research access